Core Insights - Merck reported $16.4 billion in revenue for Q4 2025, a 5% year-over-year increase, with an EPS of $2.04 compared to $1.72 a year ago, exceeding Zacks Consensus Estimates for both revenue and EPS [1] Financial Performance - Revenue surprise was +1.33% over the Zacks Consensus Estimate of $16.19 billion, while the EPS surprise was +0.62% over the consensus estimate of $2.03 [1] - Merck's shares returned +5.5% over the past month, outperforming the Zacks S&P 500 composite's +1.8% change [3] Key Product Sales - Hospital Acute Care (Bridion) in the U.S. generated $451 million, exceeding the estimated $418.39 million, reflecting an 18.1% year-over-year increase [4] - Oncology (Keytruda) international sales reached $3.45 billion, surpassing the $3.39 billion estimate, with a 15% year-over-year increase [4] - Diabetes (Janumet) in the U.S. reported $57 million, below the estimated $69.57 million, marking a significant decline of 37.4% year-over-year [4] - Oncology (Lynparza) alliance revenue in the U.S. was $180 million, slightly above the $176.62 million estimate, with a 1.7% year-over-year increase [4] - Cardiovascular (Winrevair) sales were $467 million, exceeding the estimated $452.86 million [4] - Vaccines (Vaxneuvance) generated $140 million, below the $178.52 million estimate, reflecting a 13% year-over-year decline [4] - Oncology (Welireg) sales reached $220 million, surpassing the $195.53 million estimate [4] - Oncology (Keytruda) domestic sales were $8.34 billion, slightly above the $8.31 billion estimate, with a 6.4% year-over-year increase [4] - Oncology (Lenvima) alliance revenue was $272 million, exceeding the $243.71 million estimate, with a 6.7% year-over-year increase [4] - Vaccines (Gardasil) reported $1.03 billion, close to the $1.04 billion estimate, but down 33.5% year-over-year [4] - Virology (Lagevrio) sales were $57 million, above the $45.95 million estimate, but down 52.9% year-over-year [4] - Oncology (Reblozyl) alliance revenue was $164 million, exceeding the $138.97 million estimate, with a significant 49.1% year-over-year increase [4]

Adobe Inc. (NASDAQ:ADBE) stock fell to a new 52-week low on Tuesday amid broader technology sector weakness and mounting competition.Broader Market Weakness Drives DeclineThe move comes as Technology stocks are broadly lower today, with the sector experiencing a 2.4% loss, contributing to the overall downturn. Despite the significant drop, there are no specific company-related news events driving this price action. The broader market context shows the Nasdaq down 1.31% and the S&P 500 down 0.56%, indicating ...

Financial Performance - Hess Midstream LP reported fourth-quarter 2025 earnings per share of $0.72, meeting analyst expectations, while revenue was $404.2 million, falling short of the forecast of $417.05 million [1] - The net income for the quarter totaled $168.0 million, with $93.3 million attributable to Hess Midstream LP [2] - Adjusted EBITDA reached $309.1 million, and adjusted free cash flow totaled $207.8 million, indicating resilient financial performance despite lower throughput volumes [2] Operational Metrics - Throughput volumes declined year over year across all segments: oil terminaling volumes decreased by 4%, gas processing by 1%, and water gathering by 5% [3] - The declines in throughput were primarily attributed to reduced production caused by severe winter weather [3] - Capital expenditures for the quarter totaled $47.6 million, down 44% from the prior-year period, reflecting the completion of gas compression expansion projects [3]

Core Insights - Aptiv PLC reported fourth-quarter results that exceeded analyst expectations, with adjusted earnings per share of $1.86, slightly above the consensus estimate of $1.84 [1] - Revenue for the quarter reached $5.2 billion, surpassing expectations of $5.09 billion and reflecting a 5% year-over-year increase, although organic growth moderated to 3% after adjusting for currency and commodity impacts [1] Regional Performance - Regional performance showed mixed results, with North America growing by 8% and South America by 12%, while Europe and Asia both experienced a decline of 1% [2] - The adjusted operating margin contracted to 11.8% from 12.7% a year earlier, primarily due to $66 million in higher commodity costs and foreign exchange impacts [2] Full-Year and Future Outlook - For the full year 2025, Aptiv reported revenue of $20.4 billion, an increase of 3% year over year, or 2% on an adjusted basis [3] - The company announced plans to spin off its Electrical Distribution Systems business under the name Versigent [3] - Looking ahead, Aptiv forecasts fiscal 2026 revenue between $21.12 billion and $21.82 billion, with adjusted earnings per share projected between $8.15 and $8.75, broadly in line with analyst expectations [3]

Core Insights - ArcBest Corp reported mixed fourth-quarter 2025 results with revenue of $972.7 million, down from $1.0 billion a year earlier, and adjusted earnings of 36 cents per share, missing the analyst estimate of 41 cents [1] - The results included a $9.1 million after-tax, noncash impairment charge [1] Group 1: Financial Performance - Revenue for the fourth quarter was $972.7 million, exceeding expectations of $966.361 million [1] - Adjusted earnings per share were 36 cents, which fell short of the analyst estimate of 41 cents [1] - The company faced a $9.1 million after-tax, noncash impairment charge impacting overall financial results [1] Group 2: Management Commentary - The President and CEO highlighted 2025 as a year of strong execution and meaningful progress despite a challenging freight environment [2] - The company achieved growth in LTL shipments and tonnage, restored profitability in Asset-Light, and reached record productivity levels [2] Group 3: Stock Performance and Analyst Ratings - ArcBest shares increased by 6.4% to trade at $96.01 following the earnings announcement [2] - Analysts have adjusted their price targets, with Jefferies raising it from $95 to $110 while maintaining a Buy rating [4] - JP Morgan maintained a Neutral rating and raised the price target from $76 to $81, and Wells Fargo maintained an Equal-Weight rating with a price target increase from $74 to $85 [4]

Core Insights - Autoliv Inc. reported fourth-quarter 2025 adjusted earnings of $3.19 per share, exceeding the Zacks Consensus Estimate of $2.85 and reflecting a 5% year-over-year increase [1] - The company achieved net sales of $2.82 billion, surpassing the Zacks Consensus Estimate of $2.76 billion and marking a 7.7% year-over-year growth [1] Sales Performance - Organic sales grew by 4.2% year over year, exceeding the estimate of 2.6%, driven by new product launches [2] - The Airbags and Associated Products segment generated sales of $1.91 billion, beating the projection of $1.80 billion and increasing by 8.4% year over year [3] - The Seatbelts and Associated Products segment reported sales of $910 million, up 6.3% from the prior year, although it fell short of the projection of $985.8 million [4] - Regional sales in the Americas reached $841 million, exceeding the estimate of $836 million and increasing by 6.9% year over year [4] - Sales in Europe totaled $779 million, aligning with forecasts and increasing by 9% year over year [4] - Sales in China amounted to $645 million, surpassing the projection of $616.9 million and increasing by 9.8% year over year [5] - Sales in the Rest of Asia totaled $552 million, reflecting a 4.8% year-over-year increase and meeting projections [5] Financial Position - As of December 31, 2025, Autoliv had cash and cash equivalents of $604 million and long-term debt of $1.73 billion [6] - The operating cash flow for the quarter was $544 million, with capital expenditure of $110 million, resulting in a positive free cash flow of $434 million [6] - In the fourth quarter, the company repurchased 1.5 million shares [6] 2026 Guidance - Autoliv anticipates organic sales growth of around 0% for 2026 [7] - The adjusted operating margin is expected to be in the range of 10.5-11% [7] - Operating cash flow is projected to be around $1.2 billion in 2026 [7] Zacks Rank & Comparisons - Autoliv currently holds a Zacks Rank of 3 (Hold) [8] - Other better-ranked stocks in the auto sector include Ford Motor, REV Group, and PHINIA Inc., each with a Zacks Rank of 1 (Strong Buy) [8]

Merck & Co. reports Q4 2025 earnings on Tuesday, Feb. 3, 2026, before market open. Wall Street expects earnings of $2.01 per share on revenue of $16.12 billion, representing 3.1% year-over-year growth. Shares have gained 13% over the past year, outperforming the healthcare sector's broader returns. Here's what investors should watch for. This infographic outlines Wall Street's expectations for MRK's Q4 2025 earnings report on February 3, 2026, alongside analyst price targets and historical beat rates. The N ...

Core Insights - Chevron reported a net income of $2.84 billion in Q4 2025, a decrease of approximately 12.5% from $3.25 billion in Q4 2024 [1] - The company's total revenue for Q4 2025 was $46.87 billion, down 10.2% from $52.2 billion in the same period of the previous year [2] Financial Performance - Diluted earnings per share were $1.39 in Q4 2025, a fall of around 24.5% from $1.84 in Q4 2024 [1] - Adjusted earnings were $3.02 billion for Q4 2025, down by approximately 16.8% from $3.63 billion in the same quarter last year [1] - Adjusted diluted earnings per share stood at $1.52 in Q4 2025, compared to $2.06 in Q4 2024, a decrease of around 26.2% [2] Operational Highlights - Cash flow from operations rose to $10.8 billion in Q4 2025, an increase of roughly 24.1% from $8.7 billion in the same quarter of the previous year [2] - Excluding working capital adjustments, cash flow from operations increased to $9.1 billion in Q4 2025 from $5.3 billion in Q4 2024, an increase of approximately 71.7% [4] Segment Performance - Chevron earned $3.03 billion in Q4 2025 through its upstream segment, which is around 29.5% lower than the $4.3 billion achieved in Q4 2024 [3] - The downstream segment reported earnings of $823 million in Q4 2025, compared to a loss of $248 million in Q4 2024 [3] - The 'All Other' category reported a loss of $1.08 billion in Q4 2025, compared to a loss of $817 million in Q4 2024 [3] Annual Overview - The company's net income for the full year 2025 was $12.48 billion, down by approximately 29.7% from $17.75 billion in 2024 [5] - Total revenue for the full year 2025 was $189.03 billion, a decrease of around 6.8% from $202.79 billion in 2024 [5] - Chevron achieved record oil-equivalent production levels globally and in the US, aided by the Hess acquisition, which added 261,000 barrels of oil equivalent per day [5] Reserves and Investments - Year-end proved reserves stood at around 10.6 billion barrels of net oil equivalent, with significant additions from Hess and new projects in the Permian Basin, Australia, and Guyana, resulting in a reserve replacement ratio of 158% [6] - Capital expenditure rose due to investments in legacy Hess assets and US data center power solutions, despite reduced downstream spending [6] Strategic Moves - Through the completion of the Hess acquisition, Chevron achieved a $1 billion synergy target [7] - The company commenced production at key projects in Kazakhstan and the Gulf of Mexico during Q4 [7]

Core Viewpoint - Wall Street anticipates significant growth in U.S. sales and robust profitability for Palantir as the company prepares to report its earnings, despite its stock being highly valued [1] Group 1 - Analysts expect Palantir to demonstrate strong financial performance, driven by increasing demand for its data analytics solutions [1] - The company's stock is currently considered richly valued, indicating high investor expectations for future growth [1] - There is a focus on the potential for Palantir to capitalize on expanding market opportunities in the technology sector [1]

Jobs Report, Amazon, Disney, Alphabet, Palantir, and More to Watch This Week - Barron'sSkip to Main ContentThis copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.# Jobs Report, Amazon, Disney, Alphabet, Palantir, and More to Watch This WeekByDan LamShareResize---ReprintsIn this ...